Trial intelligence / Profile preview

Irbesartan in Hypertensive Patients with LVH

NCT00362037Phase 4Completed

Sponsor
Sanofi
Start
Mar 2006
Primary completion
Jun 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of irbesartan in hypertension (HTN), left ventricular hypertrophy (LVH), sponsored by Sanofi. Started Mar 2006; status: completed.

02

Drugs

irbesartan
03

Conditions

hypertension (HTN)left ventricular hypertrophy (LVH)

Beyond the preview

Go deeper on NCT00362037.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00362037.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call